Quick Takeaways
- BIOS Fund II, LP filed SCHEDULE 13D/A for IN8BIO, INC. Common Stock, par value $0.0001 per share (INAB).
- Disclosed ownership: 4%.
- Date of event: 22 Dec 2025.
BIOS Fund II, LP - 22 Dec 2025 SCHEDULE 13D/A Report for IN8BIO, INC. Common Stock, par value $0.0001 per share (INAB)
- Filing Manager
- BIOS Fund II, LP
- Reporting Manager
- BIOS Capital Management, LP
- Symbol
- INAB
- Shares outstanding
- 9,783,925 shares
- Disclosed Ownership
- 391,357 shares
- Ownership
- 4%
- Form type
- SCHEDULE 13D/A
- Filing time
- 29 Dec 2025, 16:00:52 UTC
- Date of event
- 22 Dec 2025
- Previous filing
- 08 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BIOS Fund II, LP disclosed 4% ownership in IN8BIO, INC. Common Stock, par value $0.0001 per share (INAB) on 22 Dec 2025."
What Changed
- Previous schedule filing date: 08 May 2025.
- Current filing was accepted on 29 Dec 2025, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (19)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOS Fund II, LP | 0.2% | 19,147 | 0 | 19,147 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001714576 |
| BIOS Fund II QP, LP | 0.6% | 62,554 | 0 | 62,554 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001716869 |
| BIOS Fund II NT, LP | 0.1% | 8,373 | 0 | 8,373 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001728851 |
| BIOS Incysus Co-Invest I, LP | 0.3% | 33,247 | 0 | 33,247 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001740029 |
| BIOS Fund III, LP | 0.2% | 19,024 | 0 | 19,024 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001791917 |
| BIOS Fund III QP, LP | 1.3% | 124,253 | 0 | 124,253 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001791916 |
| BIOS Fund III NT, LP | 0.2% | 20,066 | 0 | 20,066 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001791910 |
| Bios Clinical Opportunity Fund, LP | 1.1% | 104,693 | 0 | 104,693 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001988639 |
| BP Directors, LP | 0% | 0 | 0 | 0 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813311 |
| Bios Equity Partners, LP | 0% | 0 | 0 | 0 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813314 |
| Bios Equity Partners II, LP | 1.3% | 123,321 | 0 | 123,321 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813313 |
| BIOS Equity Partners III, LP | 1.7% | 163,343 | 0 | 163,343 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001831976 |
| Bios Equity COF, LP | 1.1% | 104,693 | 0 | 104,693 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0002000747 |
| Cavu Management, LP | 2.9% | 286,664 | 0 | 286,664 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813270 |
| BIOS Capital Management, LP | 4% | 391,357 | 0 | 391,357 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813845 |
| Cavu Advisors, LLC | 2.9% | 286,664 | 0 | 286,664 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813310 |
| BIOS Advisors GP, LLC | 4% | 391,357 | 0 | 391,357 | /s/ John Fucci | John Fucci/Attorney-in-Fact | 0001813844 |
| Kreis Leslie W. | 2.9% | 286,664 | 0 | 286,664 | /s/ John Fucci | John Fucci, as Attorney-in-Fact for Leslie W. Kreis, Jr. | 0001813316 |
| Fletcher Aaron G.L. | 4% | 391,357 | 0 | 391,357 | /s/ John Fucci | John Fucci, as Attorney-in-Fact for Aaron G.L. Fletcher | 0001789490 |